These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30224109)
1. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. Christensen KD; Phillips KA; Green RC; Dukhovny D Value Health; 2018 Sep; 21(9):1054-1061. PubMed ID: 30224109 [TBL] [Abstract][Full Text] [Related]
2. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Christensen KD; Vassy JL; Phillips KA; Blout CL; Azzariti DR; Lu CY; Robinson JO; Lee K; Douglas MP; Yeh JM; Machini K; Stout NK; Rehm HL; McGuire AL; Green RC; Dukhovny D; Genet Med; 2018 Dec; 20(12):1544-1553. PubMed ID: 29565423 [TBL] [Abstract][Full Text] [Related]
3. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Vassy JL; Lautenbach DM; McLaughlin HM; Kong SW; Christensen KD; Krier J; Kohane IS; Feuerman LZ; Blumenthal-Barby J; Roberts JS; Lehmann LS; Ho CY; Ubel PA; MacRae CA; Seidman CE; Murray MF; McGuire AL; Rehm HL; Green RC; Trials; 2014 Mar; 15():85. PubMed ID: 24645908 [TBL] [Abstract][Full Text] [Related]
4. Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions. Payne K; Eden M; Davison N; Bakker E Per Med; 2017 May; 14(3):235-247. PubMed ID: 29767583 [TBL] [Abstract][Full Text] [Related]
5. Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data. Alleweldt F; Kara S; Osinski A; Van Baal P; Kellerborg K; Aarestrup FM; Koopmans M Rev Sci Tech; 2017 Apr; 36(1):311-322. PubMed ID: 28926006 [TBL] [Abstract][Full Text] [Related]
6. Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. Christensen KD; Dukhovny D; Siebert U; Green RC J Pers Med; 2015 Dec; 5(4):470-86. PubMed ID: 26690481 [TBL] [Abstract][Full Text] [Related]
7. Cost analysis of whole genome sequencing in German clinical practice. Plöthner M; Frank M; von der Schulenburg JG Eur J Health Econ; 2017 Jun; 18(5):623-633. PubMed ID: 27380512 [TBL] [Abstract][Full Text] [Related]
8. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing. Jamal L; Robinson JO; Christensen KD; Blumenthal-Barby J; Slashinski MJ; Perry DL; Vassy JL; Wycliff J; Green RC; McGuire AL AJOB Empir Bioeth; 2017; 8(2):82-88. PubMed ID: 28949844 [TBL] [Abstract][Full Text] [Related]
9. GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service. Wang Y; Li G; Ma M; He F; Song Z; Zhang W; Wu C BMC Genomics; 2018 Jan; 19(Suppl 1):959. PubMed ID: 29363427 [TBL] [Abstract][Full Text] [Related]
10. Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project. Roberts JS; Robinson JO; Diamond PM; Bharadwaj A; Christensen KD; Lee KB; Green RC; McGuire AL; Genet Med; 2018 Sep; 20(9):1069-1076. PubMed ID: 29300387 [TBL] [Abstract][Full Text] [Related]
11. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer. Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123 [TBL] [Abstract][Full Text] [Related]
12. Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project. Machini K; Ceyhan-Birsoy O; Azzariti DR; Sharma H; Rossetti P; Mahanta L; Hutchinson L; McLaughlin H; ; Green RC; Lebo M; Rehm HL Am J Hum Genet; 2019 Jul; 105(1):177-188. PubMed ID: 31256874 [TBL] [Abstract][Full Text] [Related]
13. Personalised medicine in the UK. The Lancet Lancet; 2018 Jan; 391(10115):e1. PubMed ID: 29275870 [No Abstract] [Full Text] [Related]
14. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Schwarze K; Buchanan J; Fermont JM; Dreau H; Tilley MW; Taylor JM; Antoniou P; Knight SJL; Camps C; Pentony MM; Kvikstad EM; Harris S; Popitsch N; Pagnamenta AT; Schuh A; Taylor JC; Wordsworth S Genet Med; 2020 Jan; 22(1):85-94. PubMed ID: 31358947 [TBL] [Abstract][Full Text] [Related]
15. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. McLaughlin HM; Ceyhan-Birsoy O; Christensen KD; Kohane IS; Krier J; Lane WJ; Lautenbach D; Lebo MS; Machini K; MacRae CA; Azzariti DR; Murray MF; Seidman CE; Vassy JL; Green RC; Rehm HL; BMC Med Genet; 2014 Dec; 15():134. PubMed ID: 25714468 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analyses of genetic and genomic diagnostic tests. Payne K; Gavan SP; Wright SJ; Thompson AJ Nat Rev Genet; 2018 Apr; 19(4):235-246. PubMed ID: 29353875 [TBL] [Abstract][Full Text] [Related]
17. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine. Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238 [TBL] [Abstract][Full Text] [Related]
18. Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions. Wordsworth S; Doble B; Payne K; Buchanan J; Marshall DA; McCabe C; Regier DA Value Health; 2018 Sep; 21(9):1048-1053. PubMed ID: 30224108 [TBL] [Abstract][Full Text] [Related]
19. Genomics of AML: clinical applications of next-generation sequencing. Welch JS; Link DC Hematology Am Soc Hematol Educ Program; 2011; 2011():30-5. PubMed ID: 22160009 [TBL] [Abstract][Full Text] [Related]